期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

卵巢癌的实验诊断新进展

下载PDF
导出
摘要 卵巢癌占女性恶性肿瘤的4%。晚期卵巢癌5年存活率只有5%～15%,在妇科死亡原因中占首位,严重危害女性的生命健康。而早期卵巢癌（Ⅰ期）患者5年存活率可达90%以上,
作者 高怡 刘晓艳
机构地区 复旦大学附属妇产科医院检验科
出处 《实验与检验医学》 CAS 2011年第6期615-616,664,共3页 Experimental and Laboratory Medicine
关键词 卵巢癌 诊断 进展
分类号 R730.43 [医药卫生—肿瘤] R737.31 [医药卫生—肿瘤]
  • 相关文献

参考文献21

  • 1王继贵.卵巢癌新的血清生物标志物[J].实验与检验医学,2010,28(5):468-468. 被引量：5
  • 2Moor RG,Momeekin DS,Brown AK,et al.A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass[J].Gynecol Oncol,2009,112:40-46.
  • 3卢仁泉,郭林,沈烨红.HE4在卵巢癌诊治中的临床应用评价[J].中国癌症杂志,2010,20(9):680-685. 被引量：39
  • 4董丽,昌晓红,叶雪,朱丽荣,赵旸,田莉,程洪艳,李小平,张虹,廖秦平,付天云,成夜霞,崔恒.血清人附睾分泌蛋白4和CA125水平检测在卵巢恶性肿瘤中的诊断价值[J].中华妇产科杂志,2008,43(12):931-936. 被引量：98
  • 5Huhtinen K,Suvitie P,Hiissa J,et al.Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts[J].Br J Cancer,2009,100(8):1315-1319.
  • 6Mor G,Visintin I,Lai YL,et al.Serum protein markers for early detection of ovarian cancer[J].Proc Natl Acad Sci,2005,102(21):7677-7682.
  • 7Lu D,Knhn E,Bristow RE,et al.Comparison of candidate serologic markers for type Ⅰ and type Ⅱ ovarian cancer[J].Gynecol Oncol,2011,122(3):560-566.
  • 8Hwang J,Na S Lee H,et al.Correlation between preoperative serum levels of five biomarkers and relationships between these bionarkers and cancer stage in epithelial overian cancer[J].J Gynecol Oncol,2009,20(3):169-175.
  • 9Kim K,Visintin I,Alvero AB,et al.Development and validation of a protein-based signature for the detection of ovarian cancer[J].Clin Lab Med,2009,29(1):47-55.
  • 10Nakae M,Iwamoto I,Fujino T,et al.Preoperative plasma osteopontin level as a biomarker complementary to carbohydrate antigen 125 in predicting ovarian cancer[J].J Obstet Gynaecol Res,2006,32(3):309-314.

二级参考文献37

  • 1Gadducci A, Cosio S, Carpi A, et al. Serum tumor markers in the management of ovarian, endometrial and cervical cancer. Biomed Pharmacother,2004,58 : 24 -38.
  • 2Meyer T, Rustin GJ. Role of tumour markers in monitoring epithelial ovarian cancer. Br J Cancer,2000,82 : 1535-1538.
  • 3Hellstrom I, Raycraft J, Hayden-Ledbetter M, et al. The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma. Cancer Res, 2003,63 : 3695 -3700.
  • 4Israeli O, Goldring-Aviram A, Rienstein S, et al. In sihco chromosomal clustering of genes displaying altered expression patterns in ovarian cancer. Cancer Genet Cytogenet,2005 ,160 :35- 42.
  • 5Drapkin R, von Horsten HH, Lin Y, et al. Human epididymis protein 4 ( HE4 ) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas. Cancer Res, 2005, 65:2162-2169.
  • 6Kirchhoff C, Habben I, Ivell R, et al. A major human epididymisspecific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors. Biol Reprod, 1991,45: 350- 357.
  • 7Moore RG, Brown AK, Miller MC, et al. The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass. Gynecol Oncol,2008,108:402-408.
  • 8Drapkin R,Hecht JL.The origins of ovarian cancer,hurdles and progress[J].Women's Oncol Rev,2002,2(1):261-268.
  • 9Pickle LW,Hao Y,Jemal A,et el.A new method of estimating United States and state-level cancer incidence counts for the current calendar year[J].CA Cancer J Clin,2007,57(1):30-42.
  • 102007年上海市恶性肿瘤报告[M].上海市疾病预防控制中心编制,2007:5-7.

共引文献135

实验与检验医学
2011年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部